Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis

J Allergy Clin Immunol. 2014 Mar;133(3):921-3. doi: 10.1016/j.jaci.2013.11.026. Epub 2014 Jan 10.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Asthma / drug therapy*
  • Follow-Up Studies
  • Humans
  • Interleukin-5 / antagonists & inhibitors*
  • Prospective Studies
  • Pulmonary Eosinophilia / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • mepolizumab